These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 11332169)

  • 1. Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors.
    Nordeng H; Lindemann R; Perminov KV; Reikvam A
    Acta Paediatr; 2001 Mar; 90(3):288-91. PubMed ID: 11332169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neonatal withdrawal syndrome to selective serotonin reuptake inhibitors: case report and literature review].
    Agut-Quijano T; Martínez-Nadal S; Elizari-Saco MJ; Sala-Castellví P; Vila-Cerén C; Raspall-Torrent F
    Rev Neurol; 2006 Jun 1-15; 42(11):660-2. PubMed ID: 16736401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal complications after intrauterine exposure to SSRI antidepressants.
    Prescrire Int; 2004 Jun; 13(71):103-4. PubMed ID: 15233148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
    Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
    J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do Maternal Pharmacogenetics Impact the Neonatal Abstinence Syndrome Following In Utero Exposure to Antidepressant Medications?
    Shea AK; Wang DY; Snelgrove JW; Dalfen A; Hewko S; Murphy KE
    J Obstet Gynaecol Can; 2021 Jun; 43(6):726-732. PubMed ID: 33303407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis.
    Sanz EJ; De-las-Cuevas C; Kiuru A; Bate A; Edwards R
    Lancet; 2005 Feb 5-11; 365(9458):482-7. PubMed ID: 15705457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants.
    Levinson-Castiel R; Merlob P; Linder N; Sirota L; Klinger G
    Arch Pediatr Adolesc Med; 2006 Feb; 160(2):173-6. PubMed ID: 16461873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neonatal outcome after exposure to selective serotonin reuptake inhibitors late in pregnancy].
    Cissoko H; Swortfiguer D; Giraudeau B; Jonville-Béra AP; Autret-Leca E
    Arch Pediatr; 2005 Jul; 12(7):1081-4. PubMed ID: 15964522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal adaptation in infants prenatally exposed to antidepressants--clinical monitoring using Neonatal Abstinence Score.
    Forsberg L; Navér L; Gustafsson LL; Wide K
    PLoS One; 2014; 9(11):e111327. PubMed ID: 25365553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.
    Eke AC; Saccone G; Berghella V
    BJOG; 2016 Nov; 123(12):1900-1907. PubMed ID: 27239775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paroxetine and neonatal withdrawal syndrome.
    Pogliani L; Schneider L; Dilillo D; Penagini F; Zuccotti GV
    BMJ Case Rep; 2010 Apr; 2010():. PubMed ID: 22736561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome?
    Haddad PM; Pal BR; Clarke P; Wieck A; Sridhiran S
    J Psychopharmacol; 2005 Sep; 19(5):554-7. PubMed ID: 16166193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of newer antidepressants in pregnancy.
    Way CM
    Pharmacotherapy; 2007 Apr; 27(4):546-52. PubMed ID: 17381382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.
    Tuccori M; Testi A; Antonioli L; Fornai M; Montagnani S; Ghisu N; Colucci R; Corona T; Blandizzi C; Del Tacca M
    Clin Ther; 2009 Jun; 31 Pt 1():1426-53. PubMed ID: 19698902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perinatal outcome following third trimester exposure to paroxetine.
    Costei AM; Kozer E; Ho T; Ito S; Koren G
    Arch Pediatr Adolesc Med; 2002 Nov; 156(11):1129-32. PubMed ID: 12413342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal Withdrawal Syndrome following Late in utero Exposure to Selective Serotonin Reuptake Inhibitors: A Systematic Review and Meta-Analysis of Observational Studies.
    Wang J; Cosci F
    Psychother Psychosom; 2021; 90(5):299-307. PubMed ID: 33971648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database.
    Gastaldon C; Arzenton E; Raschi E; Spigset O; Papola D; Ostuzzi G; Moretti U; Trifirò G; Barbui C; Schoretsanitis G
    Psychol Med; 2023 Sep; 53(12):5645-5653. PubMed ID: 36128628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].
    de Moor RA; Mourad L; ter Haar J; Egberts AC
    Ned Tijdschr Geneeskd; 2003 Jul; 147(28):1370-2. PubMed ID: 12892015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neonatal convulsions and subarachnoid hemorrhage after in utero exposure to paroxetine].
    Salvia-Roigés MD; Garcia L; Goncé-Mellgren A; Esqué-Ruiz MT; Figueras-Aloy J; Carbonell-Estrany X
    Rev Neurol; 2003 Apr 16-30; 36(8):724-6. PubMed ID: 12717649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.